Cingulate therapeutics headquarters
WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused … WebCingulate Therapeutics 9 years 11 months Chief Operating Officer Oct 2024 - Present5 years 7 months Kansas City, KS Founding member of …
Cingulate therapeutics headquarters
Did you know?
WebApr 3, 2024 · Cingulate Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry. Cingulate Therapeutics's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and … WebCingulate's headquarters are located at 1901 W 47th Pl, Kansas City, Kansas, 66205, United States What is Cingulate's phone number? Cingulate's phone number is (913) …
WebMay 8, 2014 · Moelis & Company acted as financial advisor to Lundbeck, while Cravath, Swaine & Moore acted as legal advisers. For Chelsea Therapeutics, Deutsche Bank Securities and Torreya Capital acted as financial advisors, while Morgan, Lewis & Bockius acted as legal advisers. Image: Lundbeck headquarters in Valby, Denmark. Photo: … WebCingulate Therapeutics is a biopharmaceutical company developing products for the treatment of central nervous system and neurobiological disorders.
WebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ … WebJun 15, 2024 · Kansas City, KS – (June 15, 2024) – Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that it has moved the location of its Kansas City headquarters.
WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that it has moved the location of …
WebJun 16, 2024 · Cingulate Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment … ipa wash bottleWebJun 15, 2024 · The new Kansas City location is at 1901 Olathe Blvd. in Kansas City, KS. About Cingulate Therapeutics Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical... open source react native appsWebAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 30, 2024 by and among Cingulate Therapeutics LLC, a Delaware limited liability company (“CTx”), Cingulate Inc., a Delaware corporation and wholly-owned subsidiary of CTx (“Parent”), and Cingulate Pharma LLC, a Delaware limited liability company and a wholly owned ... ipa walter bassoWebCingulate Therapeutics is headquartered in Mission, 1901 W 47th Pl, United States, and has 2 office locations. ipa wash stationWebApr 10, 2024 · Analyst Forecast. According to 10 analysts, the average rating for CING stock is "Buy." The 12-month stock price forecast is $5.99, which is an increase of 508.12% from the latest price. open source registry repairWebDec 8, 2024 · KANSAS CITY, Kan., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing... ipa warrantryWebCingulate is headquartered in Kansas City. For more information visit Cingulate.com. Forward-Looking Statements This press release contains certain forward-looking statements, including those relating to the use of proceeds and other statements that are predictive in nature. ipa wash strainer